ALYSON SALLING: Open Payments
NPI 1508354473 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 19 payments from 10 companies in 2025. Trend: 2023 $137 · 2024 $172 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| COLOPLAST CORP | 1 | $111 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $44 |
| Organon LLC | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Evofem Biosciences, Inc. | 5 | $29 |
| Exact Sciences Corporation | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Hologic Sales and Service, LLC | 1 | $18 |
| Medtronic, Inc. | 1 | $18 |
Products named: Altis, MYFEMBREE, Phexxi, Cologuard Collection Kit, JADA SYSTEM, Lynkuet, Veozah, APTIMA.
Industry payments across NY — which companies pay providers there.
